Cost-Effectiveness of Self-Monitoring of Blood Glucose in Type 2 Diabetic Patients Not Receiving Insulin
Response to Davidson
- Kurt Neeser, DVM,
- Katrina M. Erny-Albrecht, PHD and
- Christian Weber, MD
- Institute of Medical Informatics and Biostatistics, Basel, Switzerland
- Address correspondence to Kurt Neeser, Institute of Medical Informatics and Biostatistics (IMIB), Clarastrasse 15, Basel, Switzerland, CH-4058. E-mail: neeser{at}imib.ch
In his counterpoint article, Davidson (1) argues that self-monitoring of blood glucose (SMBG) in type 2 diabetic subjects not using insulin is a waste of money. However, as the discussions accompanying and following publication of a new meta-analysis by Welschen et al. (2) demonstrate, the evidence is far from conclusive either for or against use of SMBG in this patient group.
As pointed out by Ipp et al. (3), many of the trials of SMBG conducted thus far have …
